Aman Chauhan, MD, highlights an ongoing phase 2 trial exploring the combination of triapine, a radiation sensitizer, with ...

New nuclear reactor for medical isotope production comes online in east China's Zhejiang (Voice_over) One of China's nuclear ...

Lutetium Lu 177 dotatate is under clinical development by Advanced Accelerator Applications and currently in Phase II for Small-Cell Lung Cancer.

Lutetium Lu 177 vipivotide tetraxetan is under clinical development by Advanced Accelerator Applications and currently in Phase I for Neuroendocrine Cancer. According to GlobalData, Phase I drugs for ...

( NucNet contributed to this report) India’s state owned enterprise Nuclear Power Corporation of India Limited (NPCIL) announced this week it is inviting proposals to build a fleet of 40-50 220 MW ...

What new medicines are poised to take the leap from breakthrough to approval in 2025? Here’s what to expect this year.

China National Nuclear Corporation’s (CNNC) first-ever commercial reactor for the production of isotopes has officially ...

Scientists at Russia’s Research Institute of Nuclear Materials (INM JSC) have developed a technology for the production of ...

5190-8480安捷伦Lutetium, 1000 ug/ml, 500ml信息由福州木辰生物科技有限公司为您提供，如您想了解更多关于5190-8480安捷伦Lutetium, 1000 ug/ml, 500ml报价、型号、参数等信息，欢迎来电或留言咨询。 除供应5190-8480安捷伦Lutetium, 1000 ug/ml, 500ml外，福州木辰生物科技有限公司还可 ...

5190-8410安捷伦Lutetium, 10,000 ug/ml, 100ml信息由福州木辰生物科技有限公司为您提供，如您想了解更多关于5190-8410安捷伦Lutetium, 10,000 ug/ml, 100ml报价、型号、参数等信息，欢迎来电或留言咨询。 除供应5190-8410安捷伦Lutetium, 10,000 ug/ml, 100ml外，福州木辰生物科技有限公司 ...

Gozetotide is a drug for diagnostic application in adults with prostate cancer. It is currently the only diagnostic agent that recognizes PSMA-positive prostate cancer and can therefore identify ...